cblb612
Peptideexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02778763)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cblb612
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02778763 | Phase 2 | Dec 1, 2015 | BioLab 612 LLC, Cleveland BioLabs, Government of Russia, Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian Railways, Russian Academy of Medical Sciences, St.-Petersburg State Budgetary Healtcare Institution City Clinical Oncological Dispensary |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioLab 612 LLC | For profit | 1 | 1 | 1 | 2015 |
| Cleveland BioLabs | For profit | 1 | 0 | 1 | 2015 |
| Government of Russia | Government | 1 | 0 | 1 | 2015 |
| Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian Railways | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2015 |
| St.-Petersburg State Budgetary Healtcare Institution City Clinical Oncological Dispensary | Academic/Hospital | 1 | 0 | 1 | 2015 |
6 organizations
Page 1 / 1